Skip to main content
DNA Labs India

NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Genetic Test

Short Name: NLRP1 Gene NGS Test

Also known as: NLRP1 Mutation Analysis, NLRP1 Gene Sequencing Test, Corneal Intraepithelial Dyskeratosis Genetic Panel, Ectodermal Dysplasia NGS Panel, NLRP1 Related Autoinflammatory Disorder Test

NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Bioinformatics Analysis, Variant Classification (ACMG Guidelines) on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in 3 to 4 Weeks from sample receipt at the laboratory. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)UnisexAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this test is to identify pathogenic or likely pathogenic mutations in the NLRP1 gene responsible for corneal intraepithelial dyskeratosis and ectodermal dysplasia. Confirmation of the genetic diagnosis enables accurate clinical management, targeted ophthalmic and dermatological treatment, genetic counselling for family members, informed reproductive decisions, and participation in disease-specific research or clinical trials.

Test Code
1487
CPT Code
81479
ICD Code
Q82.8
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
3 to 4 Weeks from sample receipt at the laboratory
Fasting Required
No
Method
Next Generation Sequencing (NGS), Bioinformatics Analysis, Variant Classification (ACMG Guidelines)
Step 1

Sample Collection

A pre-test genetic counselling session is recommended to document detailed clinical history and construct a pedigree chart of affected family members. No fasting is required. Ensure the patient or guardian has provided informed consent for genetic testing.

Method: Venipuncture / Finger prick (FTA card)

Step 2

Laboratory Analysis

A 3–5 mL peripheral venous blood sample is collected in an EDTA (lavender top) vacutainer. Alternatively, a finger-prick blood sample may be deposited on an FTA card. Proper labelling with patient identifiers is essential.

Step 3

Report Delivery

The sample is transported to the laboratory at ambient room temperature. Results are delivered within 3 to 4 weeks. Genetic counselling post-test is recommended for interpretation of results and discussion of implications.

Timeline: 3 to 4 Weeks from sample receipt at the laboratory

Patient Instructions

1
Before the Test:Schedule a genetic counselling appointment to document family history and clinical symptoms. Provide informed consent. No fasting or medication adjustment is required. Carry previous medical records and any prior genetic test reports.
2
During the Test:A simple blood draw (3–5 mL) from a vein in the arm is performed, or a finger-prick sample is collected on an FTA card. The procedure takes approximately 5–10 minutes and involves minimal discomfort.
3
After the Test:Mild bruising at the puncture site may occur and resolves within a few days. Reports are available within 3 to 4 weeks via online portal, email, or WhatsApp. Post-test genetic counselling is strongly recommended to discuss findings and next steps.

About This Test

Who Should Get This Test

The primary purpose of this test is to identify pathogenic or likely pathogenic mutations in the NLRP1 gene responsible for corneal intraepithelial dyskeratosis and ectodermal dysplasia. Confirmation of the genetic diagnosis enables accurate clinical management, targeted ophthalmic and dermatological treatment, genetic counselling for family members, informed reproductive decisions, and participation in disease-specific research or clinical trials.

How to Prepare

  • Collect 3–5 mL venous blood in an EDTA (Lavender Top) vacutainer or use one drop of blood on an FTA card
  • Label the sample accurately with the patient's full name, date of birth, and unique sample ID
  • Ensure proper chain of custody documentation is completed
  • Transport the sample at ambient room temperature; avoid extreme heat or cold exposure
  • If using an extracted DNA sample, ensure a minimum concentration of 20 ng/µL and A260/A280 ratio of 1.8–2.0
  • No fasting or special preparation is required prior to sample collection

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Corneal intraepithelial dyskeratosis associated with NLRP1 mutations presents with progressive corneal clouding, reduced tear production, and photophobia. Early genetic diagnosis enables targeted ophthalmic management, preventive corneal care, and screening of at-risk family members. Patients should be evaluated for associated ectodermal features including dental anomalies, nail dystrophy, and skin changes for a comprehensive multidisciplinary care plan."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Sample Volume3–5 mL peripheral venous blood
ContainerEDTA (Lavender Top) Vacutainer or FTA Card
Collection MethodVenipuncture / Finger prick (FTA card)

Sample Stability

Whole blood in EDTA: Stable for 7 days at 2–8°C
FTA Card: Stable for several months at ambient temperature when stored dry
Extracted DNA: Stable for 6 months at –20°C
Sample Rejection Criteria:
  • Haemolysed, clotted, or insufficient sample volume
  • Incorrectly labelled or unlabeled samples
  • Samples collected in incorrect anticoagulant (e.g., heparin tubes)
  • Samples older than stability limits without prior arrangement
  • Absence of signed informed consent form

Understanding Your Results

The NLRP1 Gene NGS Genetic Test report provides a detailed analysis of all coding exons and flanking intronic regions of the NLRP1 gene. Detected variants are classified following ACMG/AMP 2015 guidelines into five categories: Pathogenic, Likely Pathogenic, Variant of Uncertain Significance (VUS), Likely Benign, and Benign. A pathogenic or likely pathogenic finding in the appropriate clinical context confirms the diagnosis of NLRP1-related corneal intraepithelial dyskeratosis or ectodermal dysplasia.
📊

Confirms a genetic diagnosis of NLRP1-related disorder. Correlate with clinical features. Recommend genetic counselling, family cascade screening, and multidisciplinary management involving ophthalmology, dermatology, and dentistry.

📊

Strong evidence supporting disease association. Clinical correlation is advised. Segregation analysis in family members may help confirm pathogenicity.

📊

Insufficient evidence to classify as pathogenic or benign. Clinical correlation, family studies, and functional data are recommended. Periodic reanalysis is advised as new evidence emerges.

📊

Variant is unlikely to be disease-causing. Clinical evaluation for alternative genetic or non-genetic causes should be considered.

📊

NLRP1 gene mutations were not identified. This does not exclude a genetic aetiology. Consider other gene panels or whole exome/genome sequencing based on clinical suspicion.

⚠️ When to Consult a Doctor:

Consult a geneticist or ophthalmologist if you or your child experience progressive corneal clouding, reduced tear production, chronic eye redness, blistering or peeling skin, abnormal hair or nail growth, missing or malformed teeth, or unexplained photosensitivity. Early diagnosis allows timely intervention and family screening.

Limitations

  • This test does not detect large structural rearrangements beyond the resolution of NGS-based CNV analysis
  • Deep intronic variants, regulatory region mutations, and mitochondrial DNA variants are not covered
  • Variants of uncertain significance (VUS) may be identified and require clinical correlation and family studies
  • This test does not replace comprehensive clinical evaluation by ophthalmology and genetics specialists
  • Negative results do not completely exclude a genetic aetiology if mutations lie outside the NLRP1 gene

Risks & Considerations

  • Minimal risk associated with blood draw – slight bruising or discomfort at the puncture site
  • Psychological impact of genetic diagnosis – genetic counselling is recommended before and after testing
  • Potential identification of variants of uncertain significance (VUS) which may cause anxiety
  • Implications for family members – a positive result may indicate inherited risk in relatives

Interfering Factors

  • Degraded or insufficient DNA quality from the sample may affect sequencing results
  • Recent blood transfusion within the past 4 weeks may lead to mixed genotype profiles
  • Haemolysed or clotted blood samples may be rejected and require recollection
  • Contamination during sample collection or transport may impact NGS library preparation

Compare With Similar Tests

TestNLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Genetic TestSanger Sequencing of NLRP1 GeneWhole Exome Sequencing (WES)Chromosomal Microarray (CMA)Whole Genome Sequencing (WGS)
ComparisonNLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Genetic Test

Frequently Asked Questions

What is the NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Genetic Test?
This is a next-generation sequencing (NGS)-based genetic test that analyses the NLRP1 gene for mutations causing corneal intraepithelial dyskeratosis and ectodermal dysplasia, a rare inherited condition affecting the eyes, skin, hair, nails, and teeth.
What symptoms suggest I should consider this genetic test?
Consider this test if you or your child have symptoms such as corneal clouding, reduced tear production, blistering or peeling skin, sparse hair, thin or dystrophic nails, dental abnormalities, palmoplantar keratoderma, photosensitivity, or abnormal sweating.
What sample is required for this test?
The test can be performed using a blood sample (3–5 mL in an EDTA vacutainer), an extracted DNA sample, or one drop of blood on an FTA card.
How much does the NLRP1 Gene NGS Genetic Test cost?
The test costs INR 20000, which includes home sample collection across India, NGS sequencing, bioinformatics analysis, and delivery of the clinical report along with raw data files.
How long does it take to receive the results?
Results are typically available within 3 to 4 weeks from the date the sample is received at the laboratory.
Is fasting required before sample collection?
No, fasting is not required. The test can be performed at any time of the day without special dietary preparation.
What files and reports will I receive with my test results?
DNA Labs India provides a conclusive clinical test report along with raw data files including FASTQ and VCF files, ensuring full transparency for any secondary analysis or second opinion.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings across major cities in India, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and many more.
Is pre-test genetic counselling required?
A pre-test genetic counselling session is strongly recommended to document the clinical history, construct a family pedigree chart, and ensure informed consent. This helps the laboratory and clinician interpret results accurately.
What does a positive (pathogenic variant detected) result mean?
A positive result confirms a genetic diagnosis of NLRP1-related disorder. This enables targeted management, family cascade screening, and informed reproductive planning. Post-test genetic counselling is recommended to discuss implications in detail.
Can this test be used for carrier screening or prenatal diagnosis?
If a pathogenic NLRP1 variant is identified in an affected family member, targeted testing for carrier status, prenatal diagnosis, or preimplantation genetic testing (PGT) can be arranged through DNA Labs India's genetic counselling team.
What should I do if my result is negative but symptoms persist?
A negative result does not completely exclude a genetic cause. Mutations in other genes may be responsible. Discuss with your geneticist or ophthalmologist about expanded gene panels or whole exome sequencing for further evaluation.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.